"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","20/25","481/2914",3.76446478364129e-12,1.52084377259108e-09,8.36107441419276e-10,"NOTCH1/CDK2/ESR1/SP1/NR0B2/MAPK1/MAPK3/CSNK2A1/RUNX2/STK11/CDK5/CREB1/TP53/CREBBP/STAT1/CTNNB1/E2F1/PRKAA1/CDK1/CSNK2B",20
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","20/25","499/2914",7.69081971625811e-12,1.55354558268414e-09,8.54085768489717e-10,"NOTCH1/CDK2/ESR1/SP1/NR0B2/MAPK1/MAPK3/CSNK2A1/RUNX2/STK11/CDK5/CREB1/TP53/CREBBP/STAT1/CTNNB1/E2F1/PRKAA1/CDK1/CSNK2B",20
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","7/25","56/2914",2.42731018995777e-07,3.26877772247646e-05,1.7970612283547e-05,"CDK2/CSNK2A1/STK11/CDK5/TP53/PRKAA1/CSNK2B",7
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/25","95/2914",6.50922429914348e-07,6.57431654213492e-05,3.61433243978757e-05,"CDK2/CSNK2A1/STK11/CDK5/TP53/PRKAA1/CDK1/CSNK2B",8
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","5/25","23/2914",9.23784516341246e-07,7.46417889203727e-05,4.10354806206322e-05,"SP1/MAPK1/MAPK3/TP53/E2F1",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","10/25","194/2914",1.84470043122961e-06,0.000124209829036127,6.82862791209556e-05,"CDK2/CSNK2A1/STK11/CDK5/TP53/CREBBP/E2F1/PRKAA1/CDK1/CSNK2B",10
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","6/25","59/2914",6.99421688595415e-06,0.00040366623170364,0.000221921768862605,"EGR1/MAPK1/MAPK3/CSNK2A1/TP53/CSNK2B",6
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","6/25","62/2914",9.38164767653723e-06,0.00047377320766513,0.000260464165756494,"ESR1/MAPK1/MAPK3/RUNX2/STAT1/CDK1",6
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","9/25","191/2914",1.51059279204649e-05,0.000678088319985315,0.000372789566224339,"CDK2/MAPK1/MAPK3/CSNK2A1/TP53/E2F1/CSNK1D/CDK1/CSNK2B",9
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/25","20/2914",1.86331710400867e-05,0.000752780110019505,0.000413852535732453,"MAPK1/MAPK3/CSNK2A1/CSNK2B",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","4/25","23/2914",3.34682340021589e-05,0.00112676387807268,0.000619455910039958,"DUSP2/MAPK1/MAPK3/CDK1",4
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","4/25","23/2914",3.34682340021589e-05,0.00112676387807268,0.000619455910039958,"NOTCH1/TP53/CREBBP/E2F1",4
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","8/25","172/2914",5.70193359215004e-05,0.0017719855163297,0.000974176508456403,"ESR1/EGR1/MAPK1/MAPK3/CSNK2A1/CREB1/TP53/CSNK2B",8
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","4/25","29/2914",8.67014302953949e-05,0.00237077294354909,0.00130336917949156,"NOTCH1/TP53/CREBBP/E2F1",4
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","3/25","11/2914",8.80237479040506e-05,0.00237077294354909,0.00130336917949156,"CDK2/TP53/E2F1",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/25","30/2914",9.94620105903099e-05,0.00251141576740532,0.00138068975227338,"CDK2/TP53/E2F1/CDK1",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","9/25","249/2914",0.000126747516415928,0.00289548863658069,0.00159183976633279,"CDK2/MAPK1/MAPK3/CSNK2A1/TP53/E2F1/CSNK1D/CDK1/CSNK2B",9
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/25","32/2914",0.000129006919451615,0.00289548863658069,0.00159183976633279,"EGR1/MAPK1/MAPK3/TP53",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/25","99/2914",0.000138538698702914,0.00294577022505143,0.00161948284910331,"CDK2/SP1/MAPK1/MAPK3/TP53/E2F1",6
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","8/25","201/2914",0.000173503763327074,0.00340648934270743,0.00187277032650148,"ESR1/EGR1/MAPK1/MAPK3/CSNK2A1/CREB1/TP53/CSNK2B",8
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/25","104/2914",0.000182323483860634,0.00340648934270743,0.00187277032650148,"NOTCH1/CREB1/TP53/CREBBP/STAT1/E2F1",6
"R-HSA-68886","R-HSA-68886","M Phase","6/25","105/2914",0.000192271742016722,0.00340648934270743,0.00187277032650148,"MAPK1/MAPK3/CSNK2A1/CSNK1D/CDK1/CSNK2B",6
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","11/25","397/2914",0.000193933799213542,0.00340648934270743,0.00187277032650148,"NOTCH1/CDK2/MAPK1/MAPK3/CSNK2A1/CDK5/CREB1/CREBBP/CTNNB1/E2F1/CSNK2B",11
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","5/25","68/2914",0.000220693305757817,0.00363163713670643,0.00199654881668853,"CDK2/TP53/E2F1/CSNK1D/CDK1",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","6/25","108/2914",0.000224730020835794,0.00363163713670643,0.00199654881668853,"ESR1/SP1/MAPK1/MAPK3/CREB1/CREBBP",6
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/25","18/2914",0.000418356469871766,0.00625985236400716,0.00344145088276579,"MAPK1/MAPK3/CREB1",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/25","18/2914",0.000418356469871766,0.00625985236400716,0.00344145088276579,"NOTCH1/CREBBP/STAT1",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","4/25","44/2914",0.000454282136912084,0.00655464226116007,0.0036035161988139,"MAPK1/MAPK3/TP53/E2F1",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/25","19/2914",0.000493987092728135,0.00665235951540555,0.00365723777423286,"CDK2/E2F1/CDK1",3
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/25","19/2914",0.000493987092728135,0.00665235951540555,0.00365723777423286,"MAPK1/MAPK3/RUNX2",3
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","4/25","47/2914",0.000586594698733764,0.00764465349317551,0.00420276677191254,"MAPK1/MAPK3/CREB1/PRKAA1",4
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","5/25","86/2914",0.000664286160028962,0.00818420200910546,0.00449939193309342,"ESR1/CSNK2A1/RUNX2/CREBBP/CSNK2B",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/25","49/2914",0.000688769476013826,0.00818420200910546,0.00449939193309342,"MAPK1/MAPK3/TP53/E2F1",4
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","4/25","49/2914",0.000688769476013826,0.00818420200910546,0.00449939193309342,"MAPK1/MAPK3/CREB1/PRKAA1",4
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","7/25","187/2914",0.000714830268339499,0.00825118366883308,0.00453621613893637,"CDK2/SP1/MAPK1/MAPK3/TP53/CREBBP/E2F1",7
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","7/25","189/2914",0.00076237972476384,0.00835769005675354,0.00459476967684991,"CDK2/SP1/MAPK1/MAPK3/TP53/CREBBP/E2F1",7
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/25","22/2914",0.000771828471348378,0.00835769005675354,0.00459476967684991,"MAPK1/MAPK3/CREB1",3
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","6/25","136/2914",0.000786119361773847,0.00835769005675354,0.00459476967684991,"ESR1/SP1/MAPK1/MAPK3/CREB1/CREBBP",6
"R-HSA-373760","R-HSA-373760","L1CAM interactions","4/25","53/2914",0.000930094144776344,0.00920900975830233,0.00506279588067168,"MAPK1/MAPK3/CSNK2A1/CSNK2B",4
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","4/25","53/2914",0.000930094144776344,0.00920900975830233,0.00506279588067168,"NOTCH1/TP53/CREBBP/CTNNB1",4
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","3/25","24/2914",0.00100296145882501,0.00920900975830233,0.00506279588067168,"MAPK1/MAPK3/CREB1",3
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","3/25","24/2914",0.00100296145882501,0.00920900975830233,0.00506279588067168,"MAPK1/MAPK3/RUNX2",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/25","24/2914",0.00100296145882501,0.00920900975830233,0.00506279588067168,"MAPK1/MAPK3/CREB1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/25","24/2914",0.00100296145882501,0.00920900975830233,0.00506279588067168,"MAPK1/MAPK3/STAT1",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","4/25","56/2914",0.00114649542894543,0.01029298118431,0.00565872597678327,"CSNK2A1/CSNK1D/CDK1/CSNK2B",4
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","8/25","268/2914",0.00124208802347992,0.0109087730757802,0.00599726711565821,"NOTCH1/ESR1/MAPK1/MAPK3/CREB1/CREBBP/STAT1/CTNNB1",8
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","3/25","26/2914",0.00127386077153991,0.010949781951109,0.00601981238062533,"ESR1/RUNX2/STAT1",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/25","101/2914",0.00138485501130868,0.0115139343406356,0.00632996390274653,"MAPK1/MAPK3/TP53/CTNNB1/E2F1",5
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","3/25","27/2914",0.00142499187384104,0.0115139343406356,0.00632996390274653,"ESR1/TP53/CDK1",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","3/25","27/2914",0.00142499187384104,0.0115139343406356,0.00632996390274653,"CDK2/CREB1/E2F1",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/25","103/2914",0.00151285518407317,0.0119841861640306,0.00658849213290894,"MAPK1/MAPK3/TP53/CTNNB1/E2F1",5
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/25","29/2914",0.00176007752806039,0.0133573979466362,0.00734343659911474,"CDK2/TP53/CDK1",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/25","29/2914",0.00176007752806039,0.0133573979466362,0.00734343659911474,"CDK2/TP53/CDK1",3
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","4/25","63/2914",0.00178539477504543,0.0133573979466362,0.00734343659911474,"ESR1/MAPK1/MAPK3/CREB1",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/25","30/2914",0.00194459036333485,0.0140288304783443,0.00771256704254987,"CSNK2A1/TP53/CSNK2B",3
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","3/25","30/2914",0.00194459036333485,0.0140288304783443,0.00771256704254987,"MAPK1/MAPK3/CREB1",3
"R-HSA-69275","R-HSA-69275","G2/M Transition","4/25","66/2914",0.00212296118118653,0.0149116026068104,0.0081978847056722,"CDK2/TP53/CSNK1D/CDK1",4
"R-HSA-391251","R-HSA-391251","Protein folding","3/25","31/2914",0.0021407746316708,0.0149116026068104,0.0081978847056722,"CSNK2A1/TP53/CSNK2B",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/25","32/2914",0.00234888853293485,0.0160839147000963,0.00884238145315351,"MAPK1/MAPK3/CREB1",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/25","33/2914",0.00256918212816601,0.0172991596629845,0.00951048121128121,"MAPK1/MAPK3/CDK1",3
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/25","34/2914",0.00280189746926929,0.018117139223932,0.0099601781559397,"DUSP2/MAPK1/MAPK3",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"MAPK3/CDK1",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"MAPK1/MAPK3",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"E2F1/CDK1",2
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"MAPK1/MAPK3",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"MAPK1/MAPK3",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"CSNK2A1/CSNK2B",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/25","10/2914",0.00304941947333509,0.018117139223932,0.0099601781559397,"MAPK1/MAPK3",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/25","37/2914",0.00357687702970256,0.0209428742028962,0.0115136697676162,"NOTCH1/CREBBP/STAT1",3
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/25","11/2914",0.00370750741231977,0.0212801506684539,0.0116990927333084,"E2F1/CDK1",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","4/25","77/2914",0.00373982845905997,0.0212801506684539,0.0116990927333084,"MAPK1/MAPK3/CREB1/PRKAA1",4
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","4/25","80/2914",0.00429535629350066,0.0232203922941416,0.0127657706463363,"CREB1/CREBBP/CSNK1D/CDK1",4
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/25","12/2914",0.00442566882833887,0.0232203922941416,0.0127657706463363,"MAPK1/MAPK3",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/25","12/2914",0.00442566882833887,0.0232203922941416,0.0127657706463363,"CSNK2A1/CSNK2B",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/25","12/2914",0.00442566882833887,0.0232203922941416,0.0127657706463363,"MAPK1/MAPK3",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/25","12/2914",0.00442566882833887,0.0232203922941416,0.0127657706463363,"MAPK1/MAPK3",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/25","12/2914",0.00442566882833887,0.0232203922941416,0.0127657706463363,"NOTCH1/CREBBP",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/25","13/2914",0.0052029083684876,0.0262746872608624,0.0144449166546169,"MAPK1/MAPK3",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/25","13/2914",0.0052029083684876,0.0262746872608624,0.0144449166546169,"NOTCH1/CREBBP",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/25","13/2914",0.0052029083684876,0.0262746872608624,0.0144449166546169,"STK11/CREBBP",2
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/25","14/2914",0.00603824216588863,0.0294283223997264,0.0161786764625906,"MAPK1/MAPK3",2
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/25","14/2914",0.00603824216588863,0.0294283223997264,0.0161786764625906,"SP1/CREBBP",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","4/25","88/2914",0.00604591772073586,0.0294283223997264,0.0161786764625906,"MAPK1/MAPK3/CREB1/PRKAA1",4
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","3/25","45/2914",0.0062431882617208,0.0299141398843478,0.0164457621563246,"CDK2/MAPK1/MAPK3",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","4/25","89/2914",0.00629381655982564,0.0299141398843478,0.0164457621563246,"MAPK1/MAPK3/CDK5/CREB1",4
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/25","15/2914",0.0069306977280032,0.0318182032058329,0.0174925504857497,"TP53/CREBBP",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/25","15/2914",0.0069306977280032,0.0318182032058329,0.0174925504857497,"TP53/CDK1",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/25","15/2914",0.0069306977280032,0.0318182032058329,0.0174925504857497,"E2F1/CDK1",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/25","16/2914",0.00787931382590942,0.0340596628413265,0.0187248276694108,"MAPK1/MAPK3",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/25","16/2914",0.00787931382590942,0.0340596628413265,0.0187248276694108,"CSNK2A1/CSNK2B",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/25","16/2914",0.00787931382590942,0.0340596628413265,0.0187248276694108,"MAPK1/MAPK3",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/25","16/2914",0.00787931382590942,0.0340596628413265,0.0187248276694108,"TP53/CDK1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/25","49/2914",0.00792477303733833,0.0340596628413265,0.0187248276694108,"MAPK1/MAPK3/CREBBP",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/25","49/2914",0.00792477303733833,0.0340596628413265,0.0187248276694108,"ESR1/SP1/CREBBP",3
"R-HSA-1643685","R-HSA-1643685","Disease","9/25","443/2914",0.00842795932665184,0.0358410059786036,0.0197041486750531,"NOTCH1/ESR1/MAPK1/MAPK3/CDK5/CREB1/CREBBP/STAT1/CTNNB1",9
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/25","17/2914",0.00888314038454034,0.0373832157849406,0.0205520024247589,"NOTCH1/CREBBP",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/25","52/2914",0.00934615777489234,0.0389262653717165,0.0214003178567801,"CREB1/CREBBP/CSNK1D",3
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","3/25","53/2914",0.0098511215926993,0.0397649534954957,0.0218613996548973,"CSNK2A1/PRKAA1/CSNK2B",3
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","2/25","18/2914",0.00994123837387391,0.0397649534954957,0.0218613996548973,"STK11/PRKAA1",2
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/25","18/2914",0.00994123837387391,0.0397649534954957,0.0218613996548973,"CDK2/CDK1",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/25","18/2914",0.00994123837387391,0.0397649534954957,0.0218613996548973,"CSNK2A1/CSNK2B",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/25","19/2914",0.0110526797010675,0.0437772803846205,0.0240672385647601,"CSNK2A1/CSNK2B",2
"R-HSA-112316","R-HSA-112316","Neuronal System","4/25","105/2914",0.0112299478891609,0.0440475625943785,0.0242158303997235,"MAPK1/MAPK3/CREB1/PRKAA1",4
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/25","20/2914",0.0122165471035297,0.0474565868252498,0.0260899943202911,"SP1/CREBBP",2
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","4/25","108/2914",0.012372677451873,0.0476053494338733,0.0261717788706287,"CSNK2A1/CREBBP/CTNNB1/CSNK2B",4
"R-HSA-111885","R-HSA-111885","Opioid Signalling","3/25","59/2914",0.013215366782787,0.0503680017004335,0.0276905897831982,"MAPK1/CDK5/CREB1",3
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","2/25","21/2914",0.0134319340429211,0.0507149659190665,0.0278813387413315,"MAPK1/MAPK3",2
"R-HSA-450294","R-HSA-450294","MAP kinase activation","3/25","60/2914",0.0138326361839773,0.0512695873240992,0.0281862504569696,"MAPK1/MAPK3/CREB1",3
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/25","60/2914",0.0138326361839773,0.0512695873240992,0.0281862504569696,"CDK2/E2F1/CDK1",3
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/25","61/2914",0.0144662684523619,0.0525484037029349,0.0288892995865536,"CSNK2A1/PRKAA1/CSNK2B",3
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/25","22/2914",0.0146979446000783,0.0525484037029349,0.0288892995865536,"CREBBP/CTNNB1",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/25","22/2914",0.0146979446000783,0.0525484037029349,0.0288892995865536,"CDK2/TP53",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/25","22/2914",0.0146979446000783,0.0525484037029349,0.0288892995865536,"CDK2/TP53",2
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/25","62/2914",0.0151163280985245,0.0531043178417729,0.0291949220026422,"CDK2/TP53/CDK1",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/25","62/2914",0.0151163280985245,0.0531043178417729,0.0291949220026422,"CDK2/CDK5/TP53",3
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","2/25","23/2914",0.0160136933708524,0.0557718286364171,0.0306614274160605,"CDK2/E2F1",2
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","3/25","64/2914",0.0164659633138539,0.0568568305880084,0.0312579240595877,"MAPK1/MAPK3/CREB1",3
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/25","119/2914",0.0172000173891759,0.0580234327817636,0.0318992817012822,"SP1/CSNK2A1/CREBBP/CSNK2B",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","2/25","24/2914",0.0173783053628549,0.0580234327817636,0.0318992817012822,"NOTCH1/CREBBP",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/25","24/2914",0.0173783053628549,0.0580234327817636,0.0318992817012822,"CDK2/TP53",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/25","24/2914",0.0173783053628549,0.0580234327817636,0.0318992817012822,"CDK2/TP53",2
"R-HSA-422475","R-HSA-422475","Axon guidance","6/25","254/2914",0.017746692100705,0.0587677344974165,0.0323084731082722,"MAPK1/MAPK3/CSNK2A1/CDK5/CREB1/CSNK2B",6
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/25","25/2914",0.0187909158931048,0.0593088282876119,0.0326059478079367,"CSNK1D/CDK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/25","25/2914",0.0187909158931048,0.0593088282876119,0.0326059478079367,"CSNK1D/CDK1",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/25","25/2914",0.0187909158931048,0.0593088282876119,0.0326059478079367,"MAPK1/MAPK3",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/25","25/2914",0.0187909158931048,0.0593088282876119,0.0326059478079367,"MAPK1/MAPK3",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/25","25/2914",0.0187909158931048,0.0593088282876119,0.0326059478079367,"ESR1/CREBBP",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/25","25/2914",0.0187909158931048,0.0593088282876119,0.0326059478079367,"CSNK2A1/CSNK2B",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/25","26/2914",0.0202506704865685,0.0619793248225279,0.0340740946783569,"MAPK1/CREB1",2
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/25","26/2914",0.0202506704865685,0.0619793248225279,0.0340740946783569,"NOTCH1/CREBBP",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/25","26/2914",0.0202506704865685,0.0619793248225279,0.0340740946783569,"CSNK1D/CDK1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/25","26/2914",0.0202506704865685,0.0619793248225279,0.0340740946783569,"CSNK1D/CDK1",2
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","3/25","70/2914",0.0209143662148585,0.0635293530135552,0.0349262467062537,"MAPK1/MAPK3/CREB1",3
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/25","27/2914",0.0217567247755867,0.0641585168564747,0.0352721392827414,"STK11/PRKAA1",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/25","27/2914",0.0217567247755867,0.0641585168564747,0.0352721392827414,"CSNK1D/CDK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/25","27/2914",0.0217567247755867,0.0641585168564747,0.0352721392827414,"CSNK1D/CDK1",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/25","27/2914",0.0217567247755867,0.0641585168564747,0.0352721392827414,"MAPK1/MAPK3",2
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","7/25","347/2914",0.0228304116352034,0.0667839059409404,0.0367154876329818,"ESR1/MAPK1/MAPK3/CDK5/CREB1/STAT1/CTNNB1",7
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/25","28/2914",0.0233082444001797,0.0667839059409404,0.0367154876329818,"CSNK1D/CDK1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/25","28/2914",0.0233082444001797,0.0667839059409404,0.0367154876329818,"MAPK1/MAPK3",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","2/25","28/2914",0.0233082444001797,0.0667839059409404,0.0367154876329818,"SP1/CREBBP",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/25","29/2914",0.0249044049092256,0.0708547857980784,0.0389535169447487,"TP53/E2F1",2
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/25","30/2914",0.0265443916625035,0.0734516043263795,0.0403811581888121,"CSNK2A1/CSNK2B",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/25","30/2914",0.0265443916625035,0.0734516043263795,0.0403811581888121,"MAPK1/MAPK3",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","2/25","30/2914",0.0265443916625035,0.0734516043263795,0.0403811581888121,"TP53/CREBBP",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/25","30/2914",0.0265443916625035,0.0734516043263795,0.0403811581888121,"MAPK1/MAPK3",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/25","77/2914",0.0268682205670181,0.0738419123066348,0.0405957360518498,"CDK2/E2F1/CDK1",3
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","3/25","78/2914",0.0277861821290047,0.0748374505341194,0.0411430486261052,"MAPK1/MAPK3/CREB1",3
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","3/25","78/2914",0.0277861821290047,0.0748374505341194,0.0411430486261052,"MAPK1/MAPK3/CREB1",3
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","3/25","78/2914",0.0277861821290047,0.0748374505341194,0.0411430486261052,"MAPK1/MAPK3/CREB1",3
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","2/25","32/2914",0.0299526338136395,0.078577039355262,0.0431989455548731,"CREB1/CREBBP",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/25","32/2914",0.0299526338136395,0.078577039355262,0.0431989455548731,"MAPK1/MAPK3",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/25","32/2914",0.0299526338136395,0.078577039355262,0.0431989455548731,"MAPK1/MAPK3",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/25","32/2914",0.0299526338136395,0.078577039355262,0.0431989455548731,"MAPK1/MAPK3",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/25","33/2914",0.0317193081159281,0.0826748417989351,0.0454517759759649,"MAPK1/MAPK3",2
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","3/25","83/2914",0.0326284584620577,0.0828872205824402,0.0455685345046766,"MAPK1/MAPK3/CREB1",3
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/25","34/2914",0.0335266462813442,0.0828872205824402,0.0455685345046766,"MAPK1/CREB1",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/25","34/2914",0.0335266462813442,0.0828872205824402,0.0455685345046766,"MAPK1/CREB1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/25","34/2914",0.0335266462813442,0.0828872205824402,0.0455685345046766,"MAPK3/STAT1",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/25","34/2914",0.0335266462813442,0.0828872205824402,0.0455685345046766,"CDK2/CDK1",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/25","34/2914",0.0335266462813442,0.0828872205824402,0.0455685345046766,"CREBBP/CTNNB1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/25","34/2914",0.0335266462813442,0.0828872205824402,0.0455685345046766,"MAPK1/MAPK3",2
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","3/25","84/2914",0.0336472875631688,0.0828872205824402,0.0455685345046766,"MAPK1/MAPK3/CREB1",3
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","3/25","84/2914",0.0336472875631688,0.0828872205824402,0.0455685345046766,"MAPK1/MAPK3/CREB1",3
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/25","35/2914",0.0353738812846291,0.0854259771166158,0.0469642552673422,"MAPK3/STAT1",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/25","35/2914",0.0353738812846291,0.0854259771166158,0.0469642552673422,"TP53/PRKAA1",2
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","3/25","86/2914",0.0357351240908615,0.0854259771166158,0.0469642552673422,"MAPK1/MAPK3/CREB1",3
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","3/25","86/2914",0.0357351240908615,0.0854259771166158,0.0469642552673422,"MAPK1/MAPK3/CREB1",3
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","3/25","86/2914",0.0357351240908615,0.0854259771166158,0.0469642552673422,"MAPK1/MAPK3/CREB1",3
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","3/25","87/2914",0.0368040686183373,0.0864467658244668,0.0475254496846339,"MAPK1/MAPK3/CREB1",3
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","3/25","87/2914",0.0368040686183373,0.0864467658244668,0.0475254496846339,"MAPK1/MAPK3/CREB1",3
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","3/25","87/2914",0.0368040686183373,0.0864467658244668,0.0475254496846339,"MAPK1/MAPK3/CREB1",3
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/25","37/2914",0.0391850198164328,0.0909813103783841,0.0500183858515869,"CSNK1D/CDK1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/25","37/2914",0.0391850198164328,0.0909813103783841,0.0500183858515869,"MAPK1/MAPK3",2
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","3/25","90/2914",0.0401105677242261,0.0920719850033372,0.0506180011352375,"MAPK1/MAPK3/CREB1",3
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","3/25","90/2914",0.0401105677242261,0.0920719850033372,0.0506180011352375,"MAPK1/MAPK3/CREB1",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/25","38/2914",0.0411474351316402,0.0933908078268687,0.0513430444280076,"CREB1/CREBBP",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/25","38/2914",0.0411474351316402,0.0933908078268687,0.0513430444280076,"MAPK1/MAPK3",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","3/25","92/2914",0.0423975318927315,0.0956905189087348,0.0526073462473764,"ESR1/MAPK1/MAPK3",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","2/25","39/2914",0.0431467706763427,0.0968405297402359,0.053239582530458,"CDK2/E2F1",2
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/25","40/2914",0.0451823047172231,0.0986683843554493,0.0542444739421569,"CDK2/CDK1",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/25","40/2914",0.0451823047172231,0.0986683843554493,0.0542444739421569,"NOTCH1/CREBBP",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/25","40/2914",0.0451823047172231,0.0986683843554493,0.0542444739421569,"CDK2/CDK1",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","2/25","40/2914",0.0451823047172231,0.0986683843554493,0.0542444739421569,"CDK2/E2F1",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/25","40/2914",0.0451823047172231,0.0986683843554493,0.0542444739421569,"NOTCH1/CREBBP",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/25","41/2914",0.0472533243095182,0.102636252801319,0.056425871133607,"MAPK1/MAPK3",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/25","97/2914",0.0484012530684187,0.103321692147177,0.0568027020402669,"EGR1/MAPK3/STAT1",3
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/25","42/2914",0.0493591252089238,0.103321692147177,0.0568027020402669,"CSNK1D/CDK1",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/25","42/2914",0.0493591252089238,0.103321692147177,0.0568027020402669,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/25","42/2914",0.0493591252089238,0.103321692147177,0.0568027020402669,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/25","42/2914",0.0493591252089238,0.103321692147177,0.0568027020402669,"MAPK1/MAPK3",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/25","42/2914",0.0493591252089238,0.103321692147177,0.0568027020402669,"EGR1/STAT1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/25","42/2914",0.0493591252089238,0.103321692147177,0.0568027020402669,"MAPK1/MAPK3",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/25","99/2914",0.0509160626489067,0.106031388196692,0.0582923994515426,"ESR1/MAPK1/MAPK3",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/25","43/2914",0.0514990117842777,0.10669538851717,0.0586574439216334,"MAPK1/MAPK3",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","4/25","172/2914",0.0560994956755031,0.115633654351547,0.0635713941328204,"CSNK2A1/CREBBP/CTNNB1/CSNK2B",4
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/25","46/2914",0.0581163566395049,0.11798496523799,0.0648640637447,"ESR1/NR0B2",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/25","46/2914",0.0581163566395049,0.11798496523799,0.0648640637447,"MAPK1/MAPK3",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/25","46/2914",0.0581163566395049,0.11798496523799,0.0648640637447,"TP53/CDK1",2
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/25","47/2914",0.060385798856941,0.121979313691021,0.0670600187306029,"SP1/CREBBP",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/25","177/2914",0.0611798041941181,0.122968362658824,0.0676037637337466,"DUSP2/MAPK1/MAPK3/CDK1",4
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","3/25","107/2914",0.061609431653989,0.123218863307978,0.0677414803490968,"ESR1/TP53/CREBBP",3
"R-HSA-168249","R-HSA-168249","Innate Immune System","7/25","428/2914",0.0624706804312317,0.124142812818159,0.0682494359161843,"MAPK1/MAPK3/CREB1/CREBBP/CTNNB1/PTPRB/CSNK2B",7
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/25","48/2914",0.0626859747893674,0.124142812818159,0.0682494359161843,"SP1/CREBBP",2
"R-HSA-2990846","R-HSA-2990846","SUMOylation","3/25","109/2914",0.0644382655719046,0.126891596291104,0.0697606222444577,"ESR1/TP53/CREBBP",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/25","49/2914",0.0650162386937091,0.126891596291104,0.0697606222444577,"MAPK1/MAPK3",2
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","2/25","49/2914",0.0650162386937091,0.126891596291104,0.0697606222444577,"STK11/CREBBP",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","3/25","110/2914",0.0658755538598395,0.127950594996996,0.0703428232005371,"MAPK1/MAPK3/CREB1",3
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/25","50/2914",0.0673759528501286,0.130238683978239,0.0716007355899125,"MAPK1/MAPK3",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/25","51/2914",0.0697644874807251,0.131092339266107,0.0720700458185214,"NOTCH1/CREBBP",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/25","51/2914",0.0697644874807251,0.131092339266107,0.0720700458185214,"NOTCH1/CREBBP",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/25","51/2914",0.0697644874807251,0.131092339266107,0.0720700458185214,"NOTCH1/CREBBP",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/25","51/2914",0.0697644874807251,0.131092339266107,0.0720700458185214,"NOTCH1/CREBBP",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/25","51/2914",0.0697644874807251,0.131092339266107,0.0720700458185214,"NOTCH1/CREBBP",2
"R-HSA-69306","R-HSA-69306","DNA Replication","2/25","51/2914",0.0697644874807251,0.131092339266107,0.0720700458185214,"CDK2/E2F1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","3/25","114/2914",0.0717751097601818,0.133767032799354,0.0735405000538398,"CDK2/TP53/CDK1",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/25","52/2914",0.0721812206689584,0.133767032799354,0.0735405000538398,"MAPK1/MAPK3",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/25","52/2914",0.0721812206689584,0.133767032799354,0.0735405000538398,"MAPK1/MAPK3",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/25","55/2914",0.0795945086624795,0.146831878993798,0.0807231017917961,"MAPK1/MAPK3",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/25","10/2914",0.0826780600904812,0.14845305011802,0.0816143657501358,"E2F1",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/25","10/2914",0.0826780600904812,0.14845305011802,0.0816143657501358,"CREB1",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/25","10/2914",0.0826780600904812,0.14845305011802,0.0816143657501358,"TP53",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/25","10/2914",0.0826780600904812,0.14845305011802,0.0816143657501358,"STAT1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/25","10/2914",0.0826780600904812,0.14845305011802,0.0816143657501358,"STAT1",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/25","10/2914",0.0826780600904812,0.14845305011802,0.0816143657501358,"CREBBP",1
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","3/25","124/2914",0.0875434560694515,0.154398086939881,0.0848827419080639,"ESR1/TP53/CDK1",3
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/25","125/2914",0.0891976183839588,0.154398086939881,0.0848827419080639,"MAPK1/PTPRB/CSNK2B",3
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","4/25","202/2914",0.0902004437751634,0.154398086939881,0.0848827419080639,"DUSP2/MAPK1/MAPK3/CDK1",4
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"STAT1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"E2F1",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"CREB1",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"CREBBP",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"TP53",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"TP53",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"CDK1",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"ESR1",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/25","11/2914",0.0905751153582967,0.154398086939881,0.0848827419080639,"STAT1",1
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","3/25","127/2914",0.0925467432534142,0.155298362588911,0.0853776824029709,"MAPK1/MAPK3/CREB1",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","5/25","289/2914",0.0944639402882242,0.155298362588911,0.0853776824029709,"SP1/CSNK2A1/STK11/CREBBP/CSNK2B",5
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","3/25","130/2914",0.0976707760645179,0.155298362588911,0.0853776824029709,"MAPK1/MAPK3/CTNNB1",3
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","2/25","62/2914",0.0977681147040943,0.155298362588911,0.0853776824029709,"MAPK1/MAPK3",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CREB1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"STAT1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"RUNX2",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CSNK1D",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CDK1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CREB1",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CSNK1D",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CDK2",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CSNK1D",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CSNK1D",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/25","12/2914",0.0984068832246565,0.155298362588911,0.0853776824029709,"CREB1",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/25","64/2914",0.103165516391522,0.161865086702839,0.0889878407876475,"NOTCH1/CREBBP",2
"R-HSA-109582","R-HSA-109582","Hemostasis","5/25","298/2914",0.104559389545386,0.161865086702839,0.0889878407876475,"CDK2/MAPK1/MAPK3/CDK5/TP53",5
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"CREB1",1
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"CREBBP",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"NOTCH1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"TP53",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"SP1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/25","13/2914",0.106173881129338,0.161865086702839,0.0889878407876475,"CDK2",1
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","6/25","393/2914",0.109776207398594,0.166087204063459,0.091309015261568,"ESR1/FBXO22/TP53/CREBBP/CSNK1D/CDK1",6
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CTNNB1",1
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"TP53",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"STAT1",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/25","14/2914",0.113876622588065,0.166087204063459,0.091309015261568,"CREBBP",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/25","15/2914",0.121515617220926,0.174086203394519,0.0957065891512336,"CDK1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/25","15/2914",0.121515617220926,0.174086203394519,0.0957065891512336,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/25","15/2914",0.121515617220926,0.174086203394519,0.0957065891512336,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/25","15/2914",0.121515617220926,0.174086203394519,0.0957065891512336,"CDK5",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/25","15/2914",0.121515617220926,0.174086203394519,0.0957065891512336,"CTNNB1",1
"R-HSA-69242","R-HSA-69242","S Phase","2/25","71/2914",0.122684617554287,0.175139878063363,0.0962858631354082,"CDK2/E2F1",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/25","16/2914",0.129091370780594,0.182352845438321,0.100251303771459,"CDK2",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/25","16/2914",0.129091370780594,0.182352845438321,0.100251303771459,"CTNNB1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/25","16/2914",0.129091370780594,0.182352845438321,0.100251303771459,"TP53",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/25","17/2914",0.136604385180347,0.191625595877987,0.105349142079873,"CDK1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/25","17/2914",0.136604385180347,0.191625595877987,0.105349142079873,"CDK2",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/25","18/2914",0.144055158521904,0.201378145476987,0.110710757414394,"E2F1",1
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","5/25","332/2914",0.147492426272862,0.205472207635298,0.112961531555622,"MAPK1/MAPK3/CREB1/TP53/STAT1",5
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/25","19/2914",0.151444185123062,0.207401528100736,0.114022205391494,"CREBBP",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/25","19/2914",0.151444185123062,0.207401528100736,0.114022205391494,"CDK1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/25","19/2914",0.151444185123062,0.207401528100736,0.114022205391494,"CREBBP",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/25","19/2914",0.151444185123062,0.207401528100736,0.114022205391494,"CTNNB1",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/25","19/2914",0.151444185123062,0.207401528100736,0.114022205391494,"CREBBP",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/25","81/2914",0.152001848385112,0.207461982255356,0.114055441000209,"CDK2/TP53",2
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/25","20/2914",0.158771955545143,0.213812900134125,0.117546956561492,"CSNK1D",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/25","20/2914",0.158771955545143,0.213812900134125,0.117546956561492,"MAPK1",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/25","20/2914",0.158771955545143,0.213812900134125,0.117546956561492,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/25","20/2914",0.158771955545143,0.213812900134125,0.117546956561492,"MAPK3",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/25","165/2914",0.165303184408104,0.221385275493671,0.121709987308923,"MAPK1/MAPK3/CREB1",3
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/25","21/2914",0.166038956620253,0.221385275493671,0.121709987308923,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/25","21/2914",0.166038956620253,0.221385275493671,0.121709987308923,"NOTCH1",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/25","87/2914",0.170236231156731,0.226234991405655,0.124376193816032,"MAPK1/MAPK3",2
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/25","22/2914",0.173245671478357,0.226508903809891,0.124526781406688,"CDK2",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/25","22/2914",0.173245671478357,0.226508903809891,0.124526781406688,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/25","22/2914",0.173245671478357,0.226508903809891,0.124526781406688,"CDK2",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/25","22/2914",0.173245671478357,0.226508903809891,0.124526781406688,"CTNNB1",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/25","22/2914",0.173245671478357,0.226508903809891,0.124526781406688,"CREB1",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/25","171/2914",0.1781272516773,0.232140031218158,0.127622580997997,"DUSP2/MAPK1/MAPK3",3
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/25","23/2914",0.180392579574153,0.233585263294736,0.128417119737335,"STAT1",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/25","23/2914",0.180392579574153,0.233585263294736,0.128417119737335,"CSNK1D",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"CREBBP",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"CDK2",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"STAT1",1
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"SP1",1
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"CREB1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"STAT1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/25","24/2914",0.187480156713775,0.237435684364781,0.130533948413154,"STAT1",1
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","2/25","94/2914",0.191978871776617,0.242373325617979,0.133248493239692,"TP53/STAT1",2
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/25","25/2914",0.194508875081302,0.242535757817426,0.133337792859502,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/25","25/2914",0.194508875081302,0.242535757817426,0.133337792859502,"CREB1",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/25","25/2914",0.194508875081302,0.242535757817426,0.133337792859502,"CTNNB1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/25","25/2914",0.194508875081302,0.242535757817426,0.133337792859502,"CDK5",1
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","2/25","97/2914",0.201422227562646,0.249685883800911,0.137268685466368,"ESR1/CREB1",2
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/25","26/2914",0.201479203265091,0.249685883800911,0.137268685466368,"CTNNB1",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/25","27/2914",0.208391606283919,0.253584966682841,0.139412266727669,"ESR1",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/25","27/2914",0.208391606283919,0.253584966682841,0.139412266727669,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/25","27/2914",0.208391606283919,0.253584966682841,0.139412266727669,"NOTCH1",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/25","27/2914",0.208391606283919,0.253584966682841,0.139412266727669,"CREBBP",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/25","27/2914",0.208391606283919,0.253584966682841,0.139412266727669,"CREBBP",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/25","27/2914",0.208391606283919,0.253584966682841,0.139412266727669,"CDK2",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/25","28/2914",0.215246545612946,0.259580908739195,0.142708628827437,"CDK1",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/25","28/2914",0.215246545612946,0.259580908739195,0.142708628827437,"ESR1",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/25","28/2914",0.215246545612946,0.259580908739195,0.142708628827437,"CREBBP",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/25","188/2914",0.215941385998831,0.259643809355737,0.14274320941652,"DUSP2/MAPK1/MAPK3",3
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/25","29/2914",0.222044479209508,0.264619379352924,0.145478606158069,"CDK1",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/25","29/2914",0.222044479209508,0.264619379352924,0.145478606158069,"STAT1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/25","29/2914",0.222044479209508,0.264619379352924,0.145478606158069,"CREB1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/25","30/2914",0.228785861538715,0.270261660998949,0.148580537964508,"CREB1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/25","30/2914",0.228785861538715,0.270261660998949,0.148580537964508,"CDK1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/25","30/2914",0.228785861538715,0.270261660998949,0.148580537964508,"CTNNB1",1
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","1/25","31/2914",0.235471143598885,0.275740121779564,0.151592406710495,"CTNNB1",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/25","31/2914",0.235471143598885,0.275740121779564,0.151592406710495,"CTNNB1",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/25","31/2914",0.235471143598885,0.275740121779564,0.151592406710495,"STAT1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/25","32/2914",0.242100772946797,0.282684139510133,0.155409988110052,"STAT1",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/25","33/2914",0.248675193722761,0.289523856668575,0.159170228653125,"CDK2",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/25","34/2914",0.255194846675531,0.292064357101741,0.160566908151296,"CDK1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/25","34/2914",0.255194846675531,0.292064357101741,0.160566908151296,"CREBBP",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/25","34/2914",0.255194846675531,0.292064357101741,0.160566908151296,"CSNK1D",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/25","34/2914",0.255194846675531,0.292064357101741,0.160566908151296,"CDK1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/25","34/2914",0.255194846675531,0.292064357101741,0.160566908151296,"TP53",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/25","34/2914",0.255194846675531,0.292064357101741,0.160566908151296,"TP53",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/25","35/2914",0.261660169187028,0.29777664324383,0.163707326014716,"CTNNB1",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/25","35/2914",0.261660169187028,0.29777664324383,0.163707326014716,"TP53",1
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","1/25","36/2914",0.268071595296901,0.304216080056034,0.167247506231952,"SP1",1
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","1/25","37/2914",0.274429555726914,0.309691453948808,0.170257677913493,"CTNNB1",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/25","37/2914",0.274429555726914,0.309691453948808,0.170257677913493,"CREBBP",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/25","38/2914",0.280734477905165,0.315924036416955,0.173684136748248,"CDK5",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","3/25","217/2914",0.284079773876615,0.318800635128202,0.17526559148528,"MAPK1/CDK5/CREB1",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/25","40/2914",0.293186900894568,0.325405241652213,0.178896576312186,"CREBBP",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/25","40/2914",0.293186900894568,0.325405241652213,0.178896576312186,"CTNNB1",1
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","1/25","40/2914",0.293186900894568,0.325405241652213,0.178896576312186,"E2F1",1
"R-HSA-69236","R-HSA-69236","G1 Phase","1/25","40/2914",0.293186900894568,0.325405241652213,0.178896576312186,"E2F1",1
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/25","41/2914",0.299335240309194,0.329513452547451,0.181155128940886,"STAT1",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/25","41/2914",0.299335240309194,0.329513452547451,0.181155128940886,"STAT1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/25","41/2914",0.299335240309194,0.329513452547451,0.181155128940886,"CREB1",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/25","42/2914",0.305432218726274,0.335311457514714,0.184342672057333,"CTNNB1",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","3/25","228/2914",0.310638835555826,0.340103223752178,0.18697701983249,"MAPK1/MAPK3/CTNNB1",3
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/25","44/2914",0.317473734684662,0.345712638308904,0.190060882447052,"ESR1",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/25","44/2914",0.317473734684662,0.345712638308904,0.190060882447052,"CDK2",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/25","45/2914",0.323419085427827,0.351240082023769,0.193099680320519,"STAT1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/25","47/2914",0.33516098211804,0.361080098068501,0.198509381689562,"STAT1",1
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","1/25","47/2914",0.33516098211804,0.361080098068501,0.198509381689562,"CDK2",1
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","1/25","47/2914",0.33516098211804,0.361080098068501,0.198509381689562,"CDK2",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/25","48/2914",0.340958322699501,0.366348836092017,0.201405952098529,"CDK2",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/25","49/2914",0.346707116116288,0.37153759923337,0.204258555076188,"STAT1",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/25","51/2914",0.358060617393724,0.382689125468424,0.210389279504527,"FBXO22",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/25","55/2914",0.380202002864164,0.40506279713241,0.222689552357839,"STK11",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","2/25","153/2914",0.380999660669099,0.40506279713241,0.222689552357839,"MAPK1/MAPK3",2
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/25","57/2914",0.390995910283876,0.414599337938808,0.227932413509871,"CTNNB1",1
"R-HSA-73894","R-HSA-73894","DNA Repair","2/25","157/2914",0.393509877489214,0.416172750014771,0.228797421191028,"CDK2/TP53",2
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/25","59/2914",0.401609232807555,0.423629582387081,0.23289693038998,"CDK2",1
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","1/25","63/2914",0.422305668150074,0.44314672709774,0.243626783266345,"SP1",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/25","63/2914",0.422305668150074,0.44314672709774,0.243626783266345,"CDK2",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/25","66/2914",0.437375186616872,0.457770920707814,0.251666660420398,"CREBBP",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/25","72/2914",0.466390001896021,0.485622579293795,0.266978541508574,"ESR1",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/25","72/2914",0.466390001896021,0.485622579293795,0.266978541508574,"CREBBP",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/25","76/2914",0.484929225845065,0.503628296250402,0.276877463545687,"CTNNB1",1
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","1/25","80/2914",0.50284924251622,0.52090024096552,0.28637298291747,"TP53",1
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","1/25","85/2914",0.524408681119972,0.541844263868207,0.297887284200603,"CTNNB1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","4/25","436/2914",0.527327137356353,0.543407244768247,0.298746557181084,"MAPK1/MAPK3/CDK5/CREB1",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","1/25","86/2914",0.52861150295525,0.543407244768247,0.298746557181084,"SP1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/25","88/2914",0.536910434274611,0.550537602657215,0.302666581971528,"FBXO22",1
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","1/25","92/2914",0.55308949397155,0.5656915330747,0.310997690147894,"CTNNB1",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/25","109/2914",0.615996199520773,0.62528257438792,0.34375878894177,"CREBBP",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/25","109/2914",0.615996199520773,0.62528257438792,0.34375878894177,"CREBBP",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/25","109/2914",0.615996199520773,0.62528257438792,0.34375878894177,"CSNK1D",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","4/25","486/2914",0.619895419437583,0.627663532463117,0.345067757555283,"MAPK1/MAPK3/CDK5/CREB1",4
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/25","115/2914",0.636096534104902,0.642457499445951,0.353200970252985,"FBXO22",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/25","126/2914",0.67035368137239,0.675368796195625,0.371294465860544,"CTNNB1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/25","144/2914",0.719832501974648,0.723413758203378,0.397707928558918,"CSNK1D",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/25","160/2914",0.75775934465641,0.759639640796997,0.417623669119766,"CSNK1D",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","1/25","296/2914",0.932092610648003,0.932092610648003,0.512432362810653,"FBXO22",1
